Skip to main content
. 2018 Feb 12;20(3):244–255. doi: 10.1016/j.neo.2018.01.004

Figure 2.

Figure 2

The mTOR pathway is activated in colorectal adenocarcinomas. A) P~mTOR Ser 2448 in the colorectal adenocarcinoma invasive front (stage IIIB, patient 11), 400×. B) Lower power version of A, 100×. C) P~mTOR Ser 2448 in the colorectal adenocarcinoma invasive front (stage IV, patient 1), 200×. D) P~S6 Ser 235/236 in the colorectal adenocarcinoma invasive front (stage IIIB, patient 11), 400×. E) Lower power version of D, 100×. F) P~S6 Ser 235/236 in the colorectal adenocarcinoma invasive front (stage IV, patient 1), 200×. Phospho-protein detected by antibody: reddish-brown color; Hematoxylin counterstain of nuclei: blue. Arrows point to invasive front.